Finally, Valisure raises the specter of opioid’s “arch-villain” Purdue: “GSK engaged in a massive, nationwide marketing campaign to convince doctors—and patients, for the first time ever—to use ...

The previous year, UK doctors were told to stop prescribing four types of Zantac as a "precautionary measure". It followed concerns in several countries that the products may contain the impurity.

And as recently announced, we have expedited retiring the risk for Zantac. We expect this to result ... under 90% would actually consider if their doctor recommended it. So that translates to ...

MEGAN McKenna has opened up about the challenges of motherhood after her newborn son, Landon, received a painful medical diagnosis. The former Towie star revealed the toll it has taken on her ...

Some analysts have drawn comparisons between Astra and rival British drugmaker GSK Plc, whose shares plummeted in August 2022 ...

“Ranitidine, used for acid reflux ... the FDA recommends continuing to take it and contacting your doctor about potential alternative treatment options. Suddenly stopping duloxetine can cause ...

ranitidine, could turn into a substance that may cause cancer when exposed to heat. What followed was tens of thousands of lawsuits against the company. In 2019, UK doctors were told to stop ...

GSK has also reached an agreement to pay $70 million to resolve the Zantac Qui Tam suit previously filed by Valisure. The arrangement is awaiting final approval from the Department of Justice.

Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

Only two commercial ranitidine products were assessed for NDMA content via analysis. Powdered samples (100 to 500 mg) were introduced to 10 mL headspace vials for headspace analysis without ...